A global biopharmaceutical company focused on the development and commercialization of prescription medicines, with major franchises in oncology, cardiovascular, renal and metabolic diseases, and rare diseases. Its revenue base is driven by patented therapies and a deep clinical pipeline, making reg...
2 members of Congress have disclosed 3 trades in AstraZeneca PLC (AZN), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2007-11-05 | MICHAEL T. MCCAUL | buy | $47,689.72 |
| 2007-09-11 | JANE HARMAN | sell | $1K – $15K |
| 2007-09-01 | JANE HARMAN | buy | $1K – $15K |